1. Home
  2. CNET vs PMCB Comparison

CNET vs PMCB Comparison

Compare CNET & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNET

ZW Data Action Technologies Inc.

N/A

Current Price

$1.39

Market Cap

5.4M

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.36

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNET
PMCB
Founded
2003
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
6.3M
IPO Year
2009
2001

Fundamental Metrics

Financial Performance
Metric
CNET
PMCB
Price
$1.39
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.3M
254.5K
Earning Date
11-13-2026
09-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $46,633,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 34.20
N/A
52 Week Low
$0.57
$0.33
52 Week High
$2.87
$1.51

Technical Indicators

Market Signals
Indicator
CNET
PMCB
Relative Strength Index (RSI) 46.55 34.43
Support Level $1.16 $0.33
Resistance Level $1.45 $0.85
Average True Range (ATR) 0.21 0.03
MACD -0.04 -0.00
Stochastic Oscillator 6.09 15.68

Price Performance

Historical Comparison
CNET
PMCB

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc provides one-stop services for clients on its Omni-channel advertising, precision marketing, influencer marketing and data analysis management system. It also develops block-chain enabled web/mobile applications and provides Software-as-a-Service services for clients. In addition, it provides intellectual property licensing services. The company derives revenue from distributing the right to use search engine marketing service it purchased from key search engines to increase the sales conversion rate for clients business promotion on both mobile and computer searches; providing internet advertising and related marketing services for clients businesses; providing intellectual property licensing services; and providing Blockchain-based SaaS Services.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: